IL22 and myeloid sarcoma: The IL-22 receptor is highly expressed in blood–brain barrier (BBB) endothelial cells from patients with MS but not in healthy controls, and IL-22 contributes to the permeabilization of the BBB and recruitment of CD4+ T lymphocytes to the CNS [10].